Heroin Withdrawal Timeline: Day-by-Day Guide

Heroin withdrawal begins within 6 to 12 hours of the last dose, producing a rapid cascade of autonomic, musculoskeletal, and gastrointestinal symptoms driven by acute diacetylmorphine deprivation.

Symptoms of heroin withdrawal peak between 48 and 72 hours and are among the most physically intense associated with any opioid withdrawal presentation. The acute phase resolves for most individuals within 5 to 7 days.

A protracted neurological recovery phase called post-acute withdrawal syndrome extends symptoms for weeks to months, particularly in individuals with long-term opioid dependence. Progression depends on duration and dosage of heroin use, route of administration, and whether concurrent polysubstance use complicates the clinical picture.

Key Takeaways

• According to SAMHSA’s 2023 National Survey on Drug Use and Health, approximately 660,000 people aged 12 and older used heroin in the past year, with fewer than one in five individuals with opioid use disorder receiving any form of treatment.
• Heroin is chemically classified as diacetylmorphine and is rapidly metabolized in the bloodstream to 6-monoacetylmorphine (6-MAM) and then morphine, producing opioid withdrawal onset in as little as 6 hours due to its short plasma half-life.
• The Clinical Opiate Withdrawal Scale (COWS) rates heroin withdrawal severity from 0 to 47; scores above 25 indicate moderately severe withdrawal requiring medical supervision to prevent dangerous complications including dehydration and cardiac instability.
• According to the CDC, heroin-involved overdose deaths numbered approximately 3,984 in 2023, with more than 80% of those deaths also involving illicitly manufactured fentanyl.
• Post-acute withdrawal syndrome affects approximately 90% of people recovering from opioid use disorder and can produce episodic depression, anxiety, anhedonia, and cravings for months following acute detox completion.

What Is Heroin Withdrawal?

Heroin withdrawal is the physiological and psychological response that emerges when the body, following sustained heroin exposure, is deprived of the opioid stimulation that has become necessary for normal neurological function. Heroin, chemically known as diacetylmorphine, is rapidly converted in the bloodstream to 6-monoacetylmorphine (6-MAM) and then morphine, which binds with high affinity to mu-opioid receptors distributed throughout the brain and peripheral nervous system.

Chronic heroin use triggers mu-opioid receptor downregulation and neuroadaptation across these systems, so that when heroin is removed, the adaptive responses activate unopposed and generate the diagnostic cluster of symptoms known as opioid withdrawal syndrome.

The DSM-5 classifies heroin-related withdrawal under opioid withdrawal, requiring three or more symptoms developing within minutes to days following cessation or significant reduction of heavy, prolonged use. Characteristic symptoms include dysphoric mood, nausea or vomiting, muscle aches, lacrimation, rhinorrhea, pupillary dilation, piloerection, diaphoresis, diarrhea, yawning, fever, and insomnia. The diagnosis also requires that symptoms cause clinically significant distress or functional impairment not better attributed to another medical condition.

Opioid Use Disorder and Heroin Dependence

Heroin use disorder is classified as opioid use disorder (OUD) under the DSM-5, with severity specifiers of mild (2 to 3 criteria met), moderate (4 to 5 criteria), and severe (6 or more criteria). Physical dependence, the state in which the nervous system requires heroin to maintain homeostasis, develops through neuroadaptation and is distinct from the full OUD diagnosis.

Individuals with heroin use disorder can develop physical dependence within weeks of regular use, and tolerance, defined by the DSM-5 as requiring markedly increased amounts to achieve the same effect, typically precedes overt dependence.

Understanding the distinction between physical dependence and opioid use disorder clarifies that withdrawal management alone does not constitute addiction treatment. The behavioral, psychiatric, and neurological dimensions of heroin use disorder require structured therapeutic care that extends well beyond the acute detox period, making outpatient programming clinically essential following medical stabilization.

What Causes Heroin Withdrawal?

Heroin withdrawal originates in the neurobiological adaptations that chronic heroin exposure induces across opioid receptor systems, noradrenergic circuits, and intracellular signaling pathways. Three primary mechanisms drive the opioid withdrawal syndrome: mu-opioid receptor downregulation, locus coeruleus hyperactivity, and adenylyl cyclase superactivation.

How Heroin Disrupts Opioid Receptor Systems

Diacetylmorphine’s rapid blood-brain barrier penetration, enabled by its high lipophilicity compared to morphine, produces intense and almost immediate mu-opioid receptor stimulation following use. Chronic exposure progressively drives compensatory receptor changes across the central nervous system:

• Mu-opioid receptor downregulation: receptor density on cell membranes decreases as neurons reduce surface receptor expression in response to persistent stimulation
• Adenylyl cyclase superactivation: intracellular cAMP-dependent enzyme systems upregulate to counteract chronic opioid inhibition
• Endogenous opioid peptide depletion: natural enkephalin and endorphin production declines as exogenous heroin input suppresses endogenous synthesis

When heroin is removed, all three compensatory mechanisms activate simultaneously without opposition, generating the neurological hyperexcitability that defines acute opioid withdrawal. Opioid dependence disrupts dopaminergic reward circuits simultaneously, producing the profound dysphoria and anhedonia that characterize heroin withdrawal’s psychological dimension.

The Locus Coeruleus and the Noradrenergic Storm

The locus coeruleus, containing approximately 50% of all central noradrenergic neurons and heavily expressing mu-opioid receptors, is the primary anatomical site of heroin withdrawal-related autonomic hyperactivity. During chronic heroin use, mu-opioid receptor stimulation tonically inhibits locus coeruleus firing. Heroin removal produces abrupt disinhibition, generating locus coeruleus hyperactivity and a noradrenergic storm that drives the autonomic withdrawal symptoms. The clinical consequences of this noradrenergic storm include:

• Anxiety, agitation, and panic from limbic and cortical noradrenergic stimulation
• Tachycardia and hypertension from cardiovascular sympathetic activation
• Diaphoresis and piloerection from peripheral noradrenergic stimulation
• Hyperreflexia and restlessness from spinal noradrenergic hyperactivity

Research published in StatPearls confirms that the locus coeruleus is “the principal site in the brain that triggers the onset of opioid withdrawal syndrome,” with noradrenergic neurons displaying markedly increased firing rates immediately upon opioid removal. Kappa-opioid receptor activation during withdrawal additionally generates the aversive dysphoric states that distinguish opioid withdrawal from other acute withdrawal presentations.

Heroin Withdrawal Timeline: Day-by-Day Breakdown

Heroin withdrawal follows a compressed timeline relative to longer-acting opioids, reflecting diacetylmorphine’s short plasma half-life of approximately 30 minutes and the subsequent rapid clearance of its active morphine metabolite over 2 to 3 hours. The five phases below describe the expected clinical progression for individuals withdrawing from heroin following sustained use.

Phase	Timeframe	Primary Symptoms	COWS Range
Onset	6–12 hours post last dose	Yawning, lacrimation, rhinorrhea, restlessness, mild diaphoresis, early cravings	Mild: 5–12
Early	12–24 hours	Myalgia, piloerection, insomnia onset, anorexia, tachycardia, nausea	Mild to Moderate: 12–18
Peak	48–72 hours	Severe nausea, vomiting, diarrhea, bone pain, fever, profuse sweating, hypertension, severe dysphoria	Moderate to Severe: 20–36+
Subacute	Days 4–7	Resolving GI symptoms, persistent insomnia, fatigue, mood lability, residual myalgia	Below 12
PAWS	Weeks 2 to 24+	Depression, anhedonia, anxiety, cognitive fog, sleep disruption, intermittent cravings	N/A

Onset Phase: 6 to 12 Hours

Heroin withdrawal onset begins 6 to 12 hours after the last dose, reflecting diacetylmorphine’s short pharmacokinetic half-life and rapid systemic clearance. Earliest symptoms during this phase include:

• Yawning, lacrimation, and rhinorrhea from initial locus coeruleus disinhibition
• Mild diaphoresis and restlessness as noradrenergic tone begins rising
• Escalating drug craving that intensifies rapidly with each hour of receptor deprivation
• COWS scoring in the mild range of 5 to 12 during this window

Clinical significance: Even at mild severity, relapse risk is substantial during the onset phase. Heroin craving intensifies quickly, and the clear physical discomfort of early withdrawal strongly motivates drug-seeking behavior in individuals without medical or psychosocial support in place.

Early Phase: 12 to 24 Hours

During the early phase of heroin withdrawal, autonomic symptoms intensify and musculoskeletal involvement emerges as opioid receptor deprivation propagates through spinal nociceptive pathways. Key developments include:

• Myalgia and bone pain developing as mu-opioid receptor inhibition of pain signaling reverses across peripheral and central pain circuits
• Piloerection and escalating diaphoresis from increasing noradrenergic tone
• Insomnia beginning as physiological hyperarousal, anxiety, and physical pain prevent sleep initiation and maintenance
• Gastrointestinal distress escalating: mild nausea progressing to persistent vomiting and early diarrhea
• Tachycardia and elevated blood pressure requiring clinical monitoring in patients with cardiovascular risk factors
• Anorexia complete by this phase, with strong aversion to food from nausea and GI distress

Peak Phase: 48 to 72 Hours

Heroin withdrawal peaks between 48 and 72 hours after the last use, producing its most physically and psychologically challenging symptoms. COWS scores frequently reach 20 to 36 during peak phase. Key risks during this window include:

• Severe dehydration from persistent vomiting and diarrhea, the primary medical danger of unsupervised heroin withdrawal
• Electrolyte imbalances including hyponatremia and hypokalemia from fluid losses, capable of precipitating cardiac arrhythmia
• Bone and muscle pain reaching maximum intensity, producing restless involuntary limb movements and preventing any sustained rest
• Severe dysphoria and panic at their most intense, with active suicidal ideation in a clinical subset requiring psychiatric monitoring
• Maximum overdose risk if relapse occurs: reduced opioid tolerance after even brief abstinence makes any return to prior doses potentially fatal

Subacute Phase: Days 4 to 7

Heroin withdrawal enters the subacute phase between days 4 and 7 as morphine clearance reduces the primary drivers of acute symptom production. What changes during this phase:

• Gastrointestinal distress resolves substantially and most severe autonomic symptoms decline in intensity
• COWS scores drop below 12 for most patients by days 5 to 6
• Persistent insomnia and profound fatigue are the most consistently reported symptoms, as sleep architecture normalization lags significantly behind other recovery indicators
• Mood instability, irritability, emotional lability, and intermittent depression emerge clearly as opioid-driven neurochemical suppression lifts
• Cravings continue but shift from acute urgency to a more generalized motivational pull that waxes and wanes with emotional states

Post-Acute Withdrawal Syndrome: Weeks 2 and Beyond

Post-acute withdrawal syndrome (PAWS) following heroin withdrawal reflects the slow restoration of endogenous opioid peptide production, mu-opioid receptor resensitization, and mesolimbic dopaminergic signaling normalization. PAWS affects approximately 90% of individuals recovering from opioid use disorder. Symptoms of heroin PAWS include:

• Persistent anhedonia and depressed mood from reduced mesolimbic dopaminergic activity in reward circuits
• Generalized anxiety and heightened stress reactivity from incomplete normalization of noradrenergic systems
• Cognitive deficits including impaired working memory, reduced attention span, and executive function difficulties
• Disrupted sleep architecture: insomnia, hypersomnia alternating, and vivid or disturbing dreams as REM systems slowly normalize
• Episodic cravings triggered by stress, environmental cues, or emotional states in a nonlinear “windows and waves” pattern
• Increased vulnerability to relapse during the neurological restoration period due to incomplete reward circuit recovery

PAWS duration ranges from weeks to 6 to 9 months for most individuals, with some reporting symptoms up to 18 to 24 months following long-duration heroin use disorder. Structured outpatient therapeutic support is clinically essential throughout this phase.

Heroin Withdrawal Symptoms

Heroin withdrawal symptoms emerge across autonomic, musculoskeletal, gastrointestinal, neurological, and psychiatric domains, reflecting the widespread distribution of mu-opioid receptors from brainstem nuclei to peripheral pain fibers. Severity and duration are influenced by duration of heroin use, average dose, route of administration, and co-occurring polysubstance use, particularly benzodiazepines, alcohol, or stimulants.

Common Heroin Withdrawal Symptoms

Most individuals withdrawing from heroin experience the following symptoms during the acute phase:

• Yawning, lacrimation (tearing eyes), and rhinorrhea (runny nose) from early locus coeruleus noradrenergic disinhibition
• Diaphoresis (profuse sweating) and piloerection (goosebumps) driven by sympathetic nervous system hyperactivation
• Myalgia and bone pain from reversal of mu-opioid receptor inhibition in spinal and peripheral nociceptive pathways
• Nausea, vomiting, diarrhea, and abdominal cramping from gastrointestinal smooth muscle hyperreactivity
• Restless legs syndrome producing involuntary limb movements that worsen overnight and further disrupt sleep
• Insomnia and sleep fragmentation driven by neurological hyperarousal throughout the acute and subacute phases
• Dysphoric mood, generalized anxiety, and intense drug craving persisting from onset through subacute phase
• Tachycardia and mild to moderate hypertension from sustained noradrenergic stimulation of cardiovascular tissue

Severe Heroin Withdrawal Symptoms

A subset of individuals with severe opioid use disorder or long-duration heroin use experience presentations requiring immediate medical attention:

• Severe dehydration from uncontrolled vomiting and diarrhea, creating risk of electrolyte imbalance and hemodynamic instability
• Electrolyte disturbances including hyponatremia and hypokalemia capable of precipitating cardiac arrhythmia and severe muscle cramping
• Sustained tachycardia above 120 beats per minute combined with significant hypertension requiring clinical monitoring
• Active suicidal ideation or acute psychiatric decompensation during peak-phase severe dysphoria
• Seizure risk in individuals with concurrent alcohol or benzodiazepine dependence, which produces an independently dangerous withdrawal syndrome requiring separate pharmacological management
• Polysubstance withdrawal complications when heroin use co-occurred with benzodiazepines: combined withdrawal presentations require concurrent management of both syndromes

Seek emergency care immediately if symptoms include uncontrolled vomiting, signs of severe dehydration, chest pain, cardiac irregularity, seizure activity, or active suicidal ideation.

Long-Term Effects of Heroin Withdrawal

Chronic heroin use disorder produces neurobiological changes that persist well beyond acute detox resolution. Long-term effects documented during the PAWS recovery phase include:

• Persistent anhedonia driven by reduced mesolimbic dopaminergic signaling in reward circuits, lasting weeks to months post-detox
• Rebound hyperalgesia: increased pain sensitivity exceeding pre-use baseline, produced by mu-opioid receptor upregulation and endorphin depletion
• Protracted insomnia and REM sleep dysregulation from slow normalization of opioid-regulated sleep architecture
• Cognitive deficits including impaired working memory, reduced sustained attention, and executive function difficulties
• Heightened emotional reactivity and stress sensitivity during the neurological restoration period
• Increased vulnerability to environmental cue-triggered relapse due to incomplete reward circuit normalization

Medications Used in Heroin Withdrawal Management

Heroin withdrawal management requires a targeted pharmacological approach addressing both the acute opioid receptor deprivation state and the autonomic dysregulation produced by locus coeruleus hyperactivity. SAMHSA guidelines support opioid agonist therapy as the clinical standard for opioid withdrawal management and long-term opioid use disorder treatment.

Buprenorphine and Medication-Assisted Treatment

Buprenorphine, a partial mu-opioid receptor agonist, suppresses heroin withdrawal symptoms by providing stable, low-level opioid receptor stimulation without the reinforcing euphoria of full agonists. Induction should begin when COWS scores reach 12 or above, confirming sufficient withdrawal progression to reduce precipitated withdrawal risk.

The combination formulation buprenorphine/naloxone (Suboxone) deters intravenous misuse through the aversive effect of the naloxone component. Better Life Recovery’s medication-assisted treatment program provides buprenorphine therapy for individuals with opioid use disorder who have completed medical stabilization and entered structured outpatient care.

Methadone Maintenance Therapy

Methadone, a full mu-opioid receptor agonist dispensed through federally licensed opioid treatment programs, provides stable receptor occupancy through its 24 to 36 hour half-life, eliminating opioid withdrawal symptoms and blocking the reinforcing effects of heroin taken on top of maintenance doses.

Long-term methadone maintenance therapy reduces opioid overdose mortality, illicit drug use, and criminal recidivism, and is recognized by SAMHSA as an essential component of comprehensive opioid use disorder treatment.

Clonidine, Naltrexone, and Supportive Medications

Clonidine reduces the autonomic symptoms of heroin withdrawal by activating alpha-2 adrenergic receptors in the locus coeruleus, suppressing the noradrenergic storm responsible for anxiety, tachycardia, diaphoresis, and piloerection. Naltrexone, an opioid antagonist initiated after complete detox, blocks the reinforcing effects of any subsequent opioid use.

Extended-release injectable naltrexone (Vivitrol) provides sustained monthly relapse prevention in individuals who have completed detox. Supportive medications used during heroin withdrawal include:

• Ondansetron or promethazine for nausea and vomiting control
• Loperamide for diarrhea management
• Hydroxyzine or low-dose gabapentin for anxiety and sleep support
• NSAIDs for myalgia during the acute phase

Heroin Withdrawal Treatment at Better Life Recovery

Better Life Recovery provides structured outpatient treatment for heroin use disorder in New Jersey, with a clinical focus on the behavioral, psychological, and neurological dimensions of recovery that follow medical detox.

All Better Life Recovery programming is outpatient, and individuals requiring acute medical detox are connected with appropriate licensed detox facilities prior to beginning outpatient treatment.

Detox Placement and Pre-Treatment Coordination

Medical detoxification from heroin should occur under physician supervision at a licensed inpatient or residential detox facility. Better Life Recovery’s medically supervised detox placement service assists individuals in New Jersey with identifying appropriate detox partners and coordinates a clinical pathway into structured outpatient treatment following stabilization.

Heroin detox without medical oversight significantly elevates risk of dangerous dehydration, cardiac complications, and overdose following any relapse at reduced opioid tolerance.

Partial Care for Heroin Use Disorder

Better Life Recovery’s partial care program provides the highest intensity of outpatient care available for individuals with opioid use disorder who have completed medical detox. The Monday through Friday schedule, from 9 AM to 2:30 PM, delivers individual therapy, group therapy, psychiatric assessment, medication management, and measurement-based care using weekly PHQ-9 and GAD-7 assessments.

This level of care addresses the behavioral and psychiatric dimensions of heroin use disorder that persist well beyond the resolution of acute withdrawal symptoms.

Intensive Outpatient Program

Better Life Recovery’s intensive outpatient program provides structured therapeutic support during the post-acute withdrawal syndrome phase, targeting the depression, anxiety, insomnia, and craving episodes that characterize opioid recovery for weeks to months following acute detox.

Evidence-based modalities including cognitive behavioral therapy, dialectical behavior therapy, and motivational interviewing address both the neurological recovery process and the behavioral patterns that sustained heroin use disorder. Same-day assessments are available for individuals ready to begin outpatient treatment.

Heroin Treatment in New Jersey

New Jersey residents seeking outpatient treatment for heroin use disorder can access Better Life Recovery’s heroin treatment program, which integrates medication-assisted treatment with evidence-based behavioral therapy across partial care, intensive outpatient, and outpatient levels of care.

A full continuum of outpatient support addresses the full arc of heroin withdrawal and recovery, from acute stabilization coordination through PAWS-phase clinical management.

Frequently Asked Questions

How Long Does Heroin Withdrawal Last?

Acute heroin withdrawal typically resolves within 5 to 7 days, with peak symptoms occurring between 48 and 72 hours after the last dose. Post-acute withdrawal syndrome extends the recovery timeline for weeks to months, producing depression, insomnia, anhedonia, and episodic cravings that require ongoing clinical management beyond acute detox completion.

Can You Die From Heroin Withdrawal?

Heroin withdrawal is rarely directly fatal for otherwise healthy individuals, unlike alcohol or benzodiazepine withdrawal. The primary dangers are severe dehydration from vomiting and diarrhea, cardiac complications from electrolyte imbalance, and relapse-related overdose at dramatically reduced opioid tolerance. Medical supervision significantly reduces all three risks through monitoring and pharmacological management.

What Are the First Signs of Heroin Withdrawal?

The first signs of heroin withdrawal typically appear within 6 to 12 hours of the last dose and include yawning, lacrimation, rhinorrhea, mild diaphoresis, restlessness, and intense drug craving. These early autonomic symptoms reflect initial disinhibition of locus coeruleus noradrenergic neurons as heroin clears from mu-opioid receptor binding sites.

What Is the Most Painful Part of Heroin Withdrawal?

The peak phase between 48 and 72 hours produces the most severe physical pain, characterized by intense myalgia, bone pain, abdominal cramping, and restless legs syndrome. The combination of extreme physical pain, severe nausea, and profound dysphoria during this window drives the majority of relapse attempts in individuals withdrawing without medical supervision or psychosocial support.

What Medications Are Used for Heroin Withdrawal?

Buprenorphine/naloxone (Suboxone) and methadone are the primary medications for heroin withdrawal management and long-term opioid use disorder treatment. Clonidine reduces autonomic symptoms off-label. Lofexidine (Lucemyra) is FDA-approved specifically for opioid withdrawal symptoms. Ondansetron, loperamide, and hydroxyzine address nausea, diarrhea, and anxiety respectively. Naltrexone or injectable naltrexone (Vivitrol) is initiated after detox completion.

What Is Post-Acute Withdrawal Syndrome After Heroin?

Post-acute withdrawal syndrome (PAWS) following heroin detox produces depression, anxiety, anhedonia, cognitive fog, sleep disruption, and episodic cravings for weeks to months. Approximately 90% of individuals recovering from opioid use disorder experience PAWS. Symptoms follow a nonlinear “windows and waves” pattern, alternating between periods of relative stability and acute symptom return.

How Does Heroin Withdrawal Differ From Fentanyl Withdrawal?

Heroin withdrawal typically resolves more quickly than fentanyl withdrawal due to heroin’s shorter half-life and lack of fat-tissue accumulation. Fentanyl’s higher potency, stronger mu-opioid receptor binding affinity, and adipose tissue sequestration contribute to more prolonged and often more severe withdrawal. Contaminated fentanyl supply further complicates management for individuals who may be uncertain which opioid they actually consumed.

Is It Safe to Detox From Heroin at Home?

Home detox from heroin is not medically recommended. Severe peak-phase symptoms including uncontrolled vomiting, diarrhea, and intense dysphoria create significant dehydration risk and relapse pressure. Any relapse following a period of abstinence dramatically elevates overdose risk due to reduced opioid tolerance. Medically supervised detox followed by structured outpatient treatment provides the safest clinical pathway.